533 related articles for article (PubMed ID: 22842367)
1. Overexpression of MDM2 protein in ameloblastomas as compared to adenomatoid odontogenic tumor.
Krishna A; Kaveri H; Naveen Kumar RK; Kumaraswamy KL; Shylaja S; Murthy S
J Cancer Res Ther; 2012; 8(2):232-7. PubMed ID: 22842367
[TBL] [Abstract][Full Text] [Related]
2. p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas.
Kumamoto H; Izutsu T; Ohki K; Takahashi N; Ooya K
J Oral Pathol Med; 2004 May; 33(5):292-9. PubMed ID: 15078490
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical comparison of the expression of p53 and MDM2 proteins in ameloblastomas and keratocystic odontogenic tumors.
Sharifi-Sistani N; Zartab H; Babakoohi S; Saghravanian N; Jamshidi S; Esmaili H; Mohtasham N; Zamanzadeh M; Abbaszadeh-Bidokhty H
J Craniofac Surg; 2011 Sep; 22(5):1652-6. PubMed ID: 21959406
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical biomarkers in ameloblastomas.
do Canto AM; Rozatto JR; Schussel JL; de Freitas RR; Hasséus B; Braz-Silva PH
Acta Odontol Scand; 2016 Nov; 74(8):585-590. PubMed ID: 27571891
[TBL] [Abstract][Full Text] [Related]
5. Expression of extracellular matrix proteins in ameloblastomas and adenomatoid odontogenic tumors.
de Medeiros AM; Nonaka CF; Galvão HC; de Souza LB; Freitas Rde A
Eur Arch Otorhinolaryngol; 2010 Feb; 267(2):303-10. PubMed ID: 19466441
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of p53 and murine double minute 2 protein in odontogenic keratocyst versus variants of ameloblastoma.
Singh A; Jain A; Shetty DC; Rathore AS; Juneja S
J Cancer Res Ther; 2020; 16(3):521-529. PubMed ID: 32719261
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD90 and P75NTR stem cell markers in ameloblastomas: a possible role in their biological behavior.
Silva FP; Dias A; Coelho CA; Guerra EN; Marques AE; Decurcio DA; Mantesso A; Cury SE; Silva BS
Braz Oral Res; 2016 Oct; 30(1):e109. PubMed ID: 27737362
[TBL] [Abstract][Full Text] [Related]
8. Caveolin-1 expression in odontogenic cysts and ameloblastomas.
Jaafari-Ashkavandi Z; Pardis S; Asadzadeh M; Andisheh-Tadbir A; Dehghani-Nazhvani A
Turk Patoloji Derg; 2014; 30(2):94-9. PubMed ID: 24782297
[TBL] [Abstract][Full Text] [Related]
9. Ameloblastoma and adenomatoid odontogenic tumor: the role of alpha2beta1, alpha3beta1, and alpha5beta1 integrins in local invasiveness and architectural characteristics.
Souza Andrade ES; da Costa Miguel MC; Pinto LP; de Souza LB
Ann Diagn Pathol; 2007 Jun; 11(3):199-205. PubMed ID: 17498594
[TBL] [Abstract][Full Text] [Related]
10. Adenomatoid odontogenic tumor (AOT) originating in a unicystic ameloblastoma: a case report.
Jivan V; Altini M; Meer S; Mahomed F
Head Neck Pathol; 2007 Dec; 1(2):146-9. PubMed ID: 20614266
[TBL] [Abstract][Full Text] [Related]
11. Comparative expression of RANK, RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas, and dentigerous cysts.
da Silva TA; Batista AC; Mendonça EF; Leles CR; Fukada S; Cunha FQ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Mar; 105(3):333-41. PubMed ID: 18061491
[TBL] [Abstract][Full Text] [Related]
12. Immunoexpression of BMP-2 and BMP-4 and their receptors, BMPR-IA and BMPR-II, in ameloblastomas and adenomatoid odontogenic tumors.
Nascimento MA; Nonaka CF; Barboza CA; Freitas RA; Pereira Pinto L; Souza LB
Arch Oral Biol; 2017 Jan; 73():223-229. PubMed ID: 27780042
[TBL] [Abstract][Full Text] [Related]
13. Immunoexpression of integrins in ameloblastoma, adenomatoid odontogenic tumor, and human tooth germs.
de Souza Andrade ES; Miguel MC; de Almeida Freitas R; Pereira Pinto L; Batista de Souza L
Int J Surg Pathol; 2008 Jul; 16(3):277-85. PubMed ID: 18573784
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of PEA3 in odontogenic cysts and tumors.
Tun KM; Kitkumthorn N; Bumalee D; Arayapisit T; Lapthanasupkul P
J Oral Pathol Med; 2023 Sep; 52(8):777-785. PubMed ID: 37549030
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of bone remodeling molecules expression in different types of jaw ameloblastoma.
Iakovou M; Chrysomali E; Piperi E; Fanourakis G; Sklavounou A; Vlachodimitropoulos D; Tseleni-Balafouta S
J Oral Pathol Med; 2015 Aug; 44(7):543-51. PubMed ID: 25243582
[TBL] [Abstract][Full Text] [Related]
16. Comparative expression of syndecan-1 and Ki-67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma.
Bologna-Molina R; Mosqueda-Taylor A; Lopez-Corella E; de Almeida OP; Carrasco-Daza D; Farfán-Morales JE; Molina-Frechero N; Damián-Matsumura P
Pathol Int; 2009 Apr; 59(4):229-33. PubMed ID: 19351365
[TBL] [Abstract][Full Text] [Related]
17. Is podoplanin expression associated with the proliferative activity of ameloblastomas?
Tjioe KC; Oliveira DT; Soares CT; Lauris JR; Damante JH
Oral Dis; 2012 Oct; 18(7):673-9. PubMed ID: 22443371
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of cyclin D1 in ameloblastomas and adenomatoid odontogenic tumors.
Kumar H; Vandana R; Kumar G
J Oral Maxillofac Pathol; 2011 Sep; 15(3):283-7. PubMed ID: 22144830
[TBL] [Abstract][Full Text] [Related]
19. Cell proliferation proteins and aggressiveness of histological variants of ameloblastoma and keratocystic odontogenic tumor.
Gupta K; Chaturvedi TP; Gupta J; Agrawal R
Biotech Histochem; 2019 Jul; 94(5):348-351. PubMed ID: 30806083
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of p53 and PCNA in ameloblastoma and adenomatoid odontogenic tumor.
Salehinejad J; Zare-Mahmoodabadi R; Saghafi S; Jafarian AH; Ghazi N; Rajaei AR; Marouzi P
J Oral Sci; 2011 Jun; 53(2):213-7. PubMed ID: 21712626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]